Fri, Oct 4, 2024
33.8 C
Dubai
More
    Home Tags AstraZeneca

    Tag: AstraZeneca

    Oxford vaccine 95% effective if given 2-3 months apart: SII

    Oxford University and UK-based AstraZeneca will soon release data showing that if the two shots are separated by around 2-3 months, the efficacy of...

    UK-based drugmaker AstraZeneca to acquire Alexion

    British pharmaceutical giant behind the most anticipated Oxford COVID-19 vaccine, AstraZeneca has decided to acquire U.S. drugmaker Alexion Pharmaceuticals for $39 billion.  The move, the...

    AstraZeneca-Sputnik V COVID-19 vaccines prepare for a combined trial

    In collaboration with the Russian Gamaleya Research Institute, the Russian Direct Investment Fund (RDIF) and R-Pharm, UK-based drugmaker AstraZeneca will conduct a clinical trial...

    Oxford COVID-19 vaccine faces tough questions after manufacturing error reveal

    After acknowledging a manufacturing error, University of Oxford and drugmaker AstraZeneca face mounting questions about their COVID-19 vaccine trial results. Although an announcement by Oxford...

    Oxford’s COVID-19 vaccine gives 70% protection: Trial results up expectations

    A large-scale study shows that the coronavirus vaccine developed by the University of Oxford in collaboration with drugmaker AstraZeneca prevents 70 percent of people...

    Phase 3 COVID-19 vaccine trial data by Christmas; Oxford researchers

    While conversing on the latest results from the ongoing late-stage trials of AstraZeneca-Oxford COVID-19 vaccine candidate, Dr. Andrew Pollard, an expert in pediatric infection...

    Oxford COVID-19 vaccine shows positive immune response in elderly

    The mid-stage trial results of a COVID-19 vaccine candidate developed by AstraZeneca Plc and Oxford University shows a strong immune response in older people. The...

    India to get 100mn Oxford vaccine shots by December: Serum Institute

    The world's largest vaccine producer, Serum Institute of India, is ramping up production of the COVID-19 shot from Oxford-AstraZeneca, hoping to have 100 million...